
Frederick Waddell
Examiner (ID: 374)
| Most Active Art Unit | 1205 |
| Art Unit(s) | 1803, 1203, 1205, 1802 |
| Total Applications | 677 |
| Issued Applications | 499 |
| Pending Applications | 0 |
| Abandoned Applications | 178 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19003610
[patent_doc_number] => 20240067681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => SUBUNIT VACCINE FOR TREATMENT OR PREVENTION OF A RESPIRATORY TRACT INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/493004
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493004
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/493004 | Subunit vaccine for treatment or prevention of a respiratory tract infection | Oct 23, 2023 | Issued |
Array
(
[id] => 18953678
[patent_doc_number] => 20240042005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => INDUCE AND ENHANCE IMMUNE RESPONSES USING RECOMBINANT REPLICON SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/492095
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18492095
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/492095 | INDUCE AND ENHANCE IMMUNE RESPONSES USING RECOMBINANT REPLICON SYSTEMS | Oct 22, 2023 | Abandoned |
Array
(
[id] => 18970456
[patent_doc_number] => 20240050548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => MHC CLASS I ASSOCIATED PEPTIDES FOR PREVENTION AND TREATMENT OF MULTIPLE FLAVI VIRUS
[patent_app_type] => utility
[patent_app_number] => 18/486459
[patent_app_country] => US
[patent_app_date] => 2023-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18486459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/486459 | MHC CLASS I ASSOCIATED PEPTIDES FOR PREVENTION AND TREATMENT OF MULTIPLE FLAVI VIRUS | Oct 12, 2023 | Abandoned |
Array
(
[id] => 19172475
[patent_doc_number] => 20240158449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHOD FOR ROBUST CONTROL OF GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/480851
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18480851
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/480851 | Method for robust control of gene expression | Oct 3, 2023 | Issued |
Array
(
[id] => 18877549
[patent_doc_number] => 20240000918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => ROTAVIRUS VACCINES
[patent_app_type] => utility
[patent_app_number] => 18/463235
[patent_app_country] => US
[patent_app_date] => 2023-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463235
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463235 | Rotavirus vaccines | Sep 6, 2023 | Issued |
Array
(
[id] => 18879080
[patent_doc_number] => 20240002449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/463276
[patent_app_country] => US
[patent_app_date] => 2023-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463276
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463276 | Respiratory syncytial virus (RSV) vaccine | Sep 6, 2023 | Issued |
Array
(
[id] => 19594231
[patent_doc_number] => 12152061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => T-cell modulatory multimeric polypeptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/237718
[patent_app_country] => US
[patent_app_date] => 2023-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 82
[patent_no_of_words] => 69246
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18237718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/237718 | T-cell modulatory multimeric polypeptides and methods of use thereof | Aug 23, 2023 | Issued |
Array
(
[id] => 19975936
[patent_doc_number] => 12343392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Compositions including Sbi adjuvants and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/235464
[patent_app_country] => US
[patent_app_date] => 2023-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 24790
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18235464
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/235464 | Compositions including Sbi adjuvants and methods of use thereof | Aug 17, 2023 | Issued |
Array
(
[id] => 18879079
[patent_doc_number] => 20240002448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => GENETICALLY ENCODED POLYPEPTIDE FOR AFFINITY CAPTURE AND PURIFICATION OF BIOLOGICS
[patent_app_type] => utility
[patent_app_number] => 18/346456
[patent_app_country] => US
[patent_app_date] => 2023-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18346456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/346456 | Genetically encoded polypeptide for affinity capture and purification of biologics | Jul 2, 2023 | Issued |
Array
(
[id] => 18861876
[patent_doc_number] => 20230416311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => INFLUENZA VACCINES
[patent_app_type] => utility
[patent_app_number] => 18/344909
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18344909
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/344909 | Influenza vaccines | Jun 29, 2023 | Issued |
Array
(
[id] => 19674495
[patent_doc_number] => 12186333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Delivery of RNA to trigger multiple immune pathways
[patent_app_type] => utility
[patent_app_number] => 18/333591
[patent_app_country] => US
[patent_app_date] => 2023-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 16744
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18333591
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/333591 | Delivery of RNA to trigger multiple immune pathways | Jun 12, 2023 | Issued |
Array
(
[id] => 18738004
[patent_doc_number] => 20230346908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => MHC CLASS I ASSOCIATED PEPTIDES FOR PREVENTION AND TREATMENT OF MULTIPLE FLAVI VIRUS
[patent_app_type] => utility
[patent_app_number] => 18/332022
[patent_app_country] => US
[patent_app_date] => 2023-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18332022
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/332022 | MHC class i associated peptides for prevention and treatment of multiple flavi virus | Jun 8, 2023 | Issued |
Array
(
[id] => 18830847
[patent_doc_number] => 20230399372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/202596
[patent_app_country] => US
[patent_app_date] => 2023-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18202596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/202596 | T-cell modulatory multimeric polypeptides and methods of use thereof | May 25, 2023 | Issued |
Array
(
[id] => 19134557
[patent_doc_number] => 11969466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Stabilized influenza hemagglutinin stem region trimers and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/314052
[patent_app_country] => US
[patent_app_date] => 2023-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 44
[patent_no_of_words] => 41843
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314052
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/314052 | Stabilized influenza hemagglutinin stem region trimers and uses thereof | May 7, 2023 | Issued |
Array
(
[id] => 18784818
[patent_doc_number] => 20230372466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => UNIVERSAL MAMMALIAN INFLUENZA VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/296150
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296150
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296150 | Universal mammalian influenza vaccine | Apr 4, 2023 | Issued |
Array
(
[id] => 20239620
[patent_doc_number] => 12419924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Methods for combining adoptive T cell therapy with oncolytic virus adjunct therapy
[patent_app_type] => utility
[patent_app_number] => 18/295994
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13541
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295994
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295994 | Methods for combining adoptive T cell therapy with oncolytic virus adjunct therapy | Apr 4, 2023 | Issued |
Array
(
[id] => 18676802
[patent_doc_number] => 20230314434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => SEMI-QUANTITATIVE LATERAL FLOW DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/194417
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18194417
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/194417 | SEMI-QUANTITATIVE LATERAL FLOW DEVICES | Mar 30, 2023 | Pending |
Array
(
[id] => 18769364
[patent_doc_number] => 20230364124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES
[patent_app_type] => utility
[patent_app_number] => 18/185891
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185891
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/185891 | METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES | Mar 16, 2023 | Abandoned |
Array
(
[id] => 18581631
[patent_doc_number] => 20230263884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING CORONAVIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/122169
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122169
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122169 | METHODS AND COMPOSITIONS FOR TREATING CORONAVIRAL INFECTIONS | Mar 15, 2023 | Pending |
Array
(
[id] => 18629538
[patent_doc_number] => 20230288420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => VERTICAL FLOW IMMUNOCHROMATOGRAPHIC ASSAY DEVICE AND METHOD OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/120656
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120656 | VERTICAL FLOW IMMUNOCHROMATOGRAPHIC ASSAY DEVICE AND METHOD OF USING THE SAME | Mar 12, 2023 | Pending |